Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital Mater DeiBSP:MATD3 +1.45%85 EV-to-EBIT is 6.98 as of Jul. 14, 2026, which is 34% below its 10-year median of 10.59. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.89 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Hospital Mater Dei ranks better than 85.04% on this metric.
The historical rank and industry rank for Hospital Mater Dei's EV-to-EBIT or its related term are showing as below:
BSP:MATD3'
s EV-to-EBIT Range Over the Past 10 Years
Min: -13.32 Med: 10.59 Max: 40.94
Current: 6.98
During the past 9 years, the highest EV-to-EBIT of Hospital Mater Dei was 40.94. The lowest was -13.32. And the median was 10.59.
BSP:MATD3's EV-to-EBIT is ranked better than 85.04% of 468
companies
in the Healthcare Providers & Services industry
Industry Median: 15.865
vs BSP:MATD3: 6.98
Hospital Mater Dei (BSP:MATD3) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Hospital Mater Dei's Enterprise Value for the quarter that ended in Mar. 2026 was R$3,493 Mil.
Hospital Mater Dei's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$461 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei EV-to-EBIT Related Terms
Hospital Mater Dei EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Hospital Mater Dei's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's EV-to-EBIT falls into.
Hospital Mater Dei's current Enterprise Value is R$3,216 Mil.
Hospital Mater Dei's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$461 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei (BSP:MATD3) has a EV-to-EBIT of 6.98 as of Jul. 14, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Hospital Mater Dei and its competitors. This is 34% below median its historical median of 10.59. According to the industry distribution chart, Hospital Mater Dei ranks #70 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 15%.
Is Hospital Mater Dei's EV-to-EBIT too high?
Hospital Mater Dei's current EV-to-EBIT of 6.98 is 34% below median its 10-year median of 10.59. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. Hospital Mater Dei's value of 6.98 is 56% below this industry median. Based on the distribution chart, Hospital Mater Dei ranks #70 out of 468 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #70 out of 468 companies for EV-to-EBIT. This places Hospital Mater Dei in the top 15% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.87. Hospital Mater Dei's value of 6.98 is 56% below this benchmark. While the company's 10-year median is 10.59 vs. the industry median of 15.87, Hospital Mater Dei has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current EV-to-EBIT of 6.98 is 56% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current EV-to-EBIT is 6.98, which is 34% below median its own 10-year median of 10.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.89, compared to a current price of R$4.91 — trading 16.6% below its estimated fair value. The current EV-to-EBIT is 6.98, which is 34% below median its 10-year median of 10.59 and 56% below the Healthcare Providers & Services industry median of 15.87. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current EV-to-EBIT is 6.98 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.91 is trading 16.6% below its estimated GF Value™ of R$5.89.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
EV-to-EBIT: 6.98 (34% below median its 10-year median of 10.59)
GF Value™: R$5.89 vs. price of R$4.91 (16.6% below fair value)
Industry Position: 56% below the Healthcare Providers & Services median (#70 of 468)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score
Get the complete analysis for BSP:MATD3
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
